Log off SitemapDisclaimer

Rheumatoid arthritis pain is relieved with Matrifen® transdermal pain relief patch

Matrifen® from Nycomed relieves the pain of rheumatoid arthritis and other severe chronic pain and it has fewer adverse effects than other similar products.

Rheumatoid arthritis
Matrifen® eases the pain of rheumatoid arthritis
Matrifen® is a well documentet pain patch, that relieves the aches and pains of rheumatoid arthritis.

>> More information on rheumatoid arthritis and Matrifen®

The Matrifen transdermal patch can be used for chronic pain in osteoarthritis patients, pheumatoid arthritis patients, patients with respiratory depression, hypoventilation and cognitive impairment.

It has fewer adverse effects compared to morphine tablets and other oral formulations of opiod analgesics and is approximately 50 to 100 times as potent as morphine.

About Nycomed
Nycomed is a pharmaceutical company dedicated to meeting needs in Europe. The company provides hospital products throughout the region and general practitioner and pharmacy medicines in selected markets.

New products are sourced through licensing agreements with research companies. Here Nycomed provides late-stage clinical development, registration and marketing. Nycomed employs about 3,500 people throughout Europe and Russia-CIS.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table